蔡燕鴻 曾振華 曹曉燕

【摘要】 目的 探討加溫濕化高流量鼻導(dǎo)管通氣（HHFNC）治療重癥肺炎的臨床療效與實(shí)用價(jià)值。方法 60例重癥肺炎患兒， 隨機(jī)分為治療組與對(duì)照組， 每組30例， 在研究過(guò)程中， 治療組無(wú)患兒退出， 對(duì)照組因各種原因退出3例患兒， 研究結(jié)束時(shí)對(duì)照組27例， 治療組30例。治療組按兒科常規(guī)護(hù)理治療， 同時(shí)給予加溫濕化高流量鼻導(dǎo)管通氣治療；對(duì)照組按兒科常規(guī)護(hù)理治療， 并予常規(guī)氧療。比較兩組的治療效果。結(jié)果 治療前兩組小兒危重病例評(píng)分法（PCIS）評(píng)分及氧分壓比較差異均無(wú)統(tǒng)計(jì)學(xué)意義（P>0.05）；治療后12～24 h治療組氧分壓高于對(duì)照組， 差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后12～24 h， 治療組總有效率80.0%高于對(duì)照組的55.6%， 差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療組呼吸困難緩解天數(shù)、心率恢復(fù)正常天數(shù)及住院治療天數(shù)均短于對(duì)照組， 差異均具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 加溫濕化高流量鼻導(dǎo)管通氣治療重癥肺炎的臨床療效顯著， 有舒適、安全、易于操作、療效顯著四大實(shí)用價(jià)值， 值得臨床推廣。

【關(guān)鍵詞】 加溫濕化高流量鼻導(dǎo)管通氣；重癥肺炎；臨床療效

DOI：10.14163/j.cnki.11-5547/r.2018.10.002

【Abstract】 Objective To discuss the clinical efficacy and practical value of humidified high flow nasal cannula （HHFNC） in the treatment of severe pneumonia. Methods A total of 60 severe pneumonia children were randomly divided into treatment group and control group， with 30 cases in each group. During the study， no children were withdrawn from the treatment group， and 3 children withdrew from the control group for various reasons. There were 27 cases in the control group and 30 cases in the treatment group at the end of the study. The treatment group received conventional nursing and humidified high flow nasal cannula for treatment， and the control group received conventional nursing and conventional oxygen therapy. The treatment effect in two groups was compared. Results Before treatment， both groups had no statistically significant difference in pediatric critical illness scale （PCIS） score and oxygen partial pressure （P>0.05）. After 12～24 h of treatment， the treatment group had higher oxygen partial pressure than the control group， and the difference was statistically significant （P<0.05）. After 12～24 h of treatment， the treatment group had higher total effective rate as 80.0% than 55.6% in the control group， and the difference was statistically significant （P<0.05）. The treatment group had shorter dyspnea remission time， heart rate back to normal time and hospitalization time than the control group， and their difference was statistically significant （P<0.05）. Conclusion Humidified high flow nasal cannula shows remarkable clinical efficacy in treating severe pneumonia with four practical vale of comfort， safety， easy operation and remarkable efficacy， and it is worthy of clinical promotion.

【Key words】 Humidified high flow nasal cannula； Severe pneumonia； Clinical efficacy

小兒肺炎為兒科的常見(jiàn)病、多發(fā)病， 病死率居我國(guó)兒科住院疾病首位， 是5歲以下兒童死亡的主要原因， 死亡病例主要為重癥肺炎[1]， 呼吸衰竭是重癥肺炎患兒死亡的主要原因[2]， 故氧療成為治療重癥肺炎重要環(huán)節(jié)。氧療可通過(guò)有創(chuàng)與無(wú)創(chuàng)呼吸支持實(shí)現(xiàn)， 本研究以無(wú)創(chuàng)氧療為研究方向。加溫濕化高流量鼻導(dǎo)管通氣是本次研究的主要研究方式， 通過(guò)臨床實(shí)際運(yùn)用分析其在治療重癥肺炎中的療效及實(shí)用性。現(xiàn)報(bào)告如下。